Internal Medicine - Issue 10/2016
Original Contributions
775
Symptomatic and asymptomatic primary hyperparathyroidism in outpatient care – current issues
Helena Šiprová, Miroslav Souček, Zdeněk Fryšák, Květoslav Šipr
Reviews
781
Raloxifene – an unexploited possibility of prevention and treatment of postmenopausal osteoporosis
Jan Štěpán, Jan Rosa, Karel Pavelka
789
Treatment of dyslipidemia – is here still place for CETP-inhibitors?
Ján Murín, Miroslav Pernický, Soňa Kiňová
795
The benefit of magnetic resonance for diagnosing cardiomyopathy and myocarditis
Michal Fikrle, Petr Kuchynka, Martin Mašek, Jana Podzimková, Jan Kuchař, Aleš Linhart, Tomáš Paleček
805
New – direct oral anticoagulants: actual review
Jana Michalcová, Miroslav Penka, Alena Buliková, Jiřina Zavřelová, Andrea Štěpařová
814
Case Reports
820
Evaluation of five years of treatment of Erdheim-Chester disease with anakinra: case report and overview of literature
Zdeněk Adam, Hana Petrášová, Zdeněk Řehák, Renata Koukalová, Marta Krejčí, Luděk Pour, Eva Vetešníková, Aleš Čermák, Sabina Ševčíková, Petr Szturz, Zdeněk Král, Jiří Mayer
833
Hemosuccus pancreaticus – rare complication of chronic pancreatitis
Igor Šturdík, Martin Kužma, Zuzana Kužmová, Tomáš Koller, Vladimír Javorka, Tibor Hlavatý, Juraj Payer
Actualities
837
Internal Medicine
2016 Issue 10
Most read in this issue
- New – direct oral anticoagulants: actual review
- Raloxifene – an unexploited possibility of prevention and treatment of postmenopausal osteoporosis
- The benefit of magnetic resonance for diagnosing cardiomyopathy and myocarditis
- Hemosuccus pancreaticus – rare complication of chronic pancreatitis